Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 5, 2014Third quarter revenue increased 7 percent to $968 million, driven by continued growth in the company's Procedural Solutions segment
SAN DIEGO, May 5, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its third quarter of fiscal 2014, ended...
-
May 2, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Deutsche Bank 39(th) Annual Health Care Conference on...
-
May 1, 2014- Announces revenues of $2.072 billion, an increase of 3.6 percent, or 5.1 percent on a foreign currency-neutral basis.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.072 billion for the second fiscal quarter ended March 31, 2014,...
-
Apr 24, 2014Also Introduces the pink Achieve® Breast Biopsy Device
SAN DIEGO, CA, March 24, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, launched its new AVAflex ® Vertebral Balloon System today at the 39th annual Scientific...
-
Apr 24, 2014Easy-to-use CD4 analysis platform tailored to meet the needs of resource-limited settings
BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSPresto(TM) Near Patient CD4...
-
Apr 22, 2014CareFusion Technology Receives Top Marks for Quality, Ease of Use and Reliability
SAN DIEGO, April 22, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced that nurses have ranked the Pyxis MedStation® system as the #1...
-
Apr 9, 2014BD MAX™ GC rt PCR Assay Receives CE Mark
BALTIMORE, MD, April 09, 2014 – BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the CE mark and launch of the BD...
-
Apr 7, 2014
SAN DIEGO, April 7, 2014 /PRNewswire/ – CareFusion Corporation (NYSE: CFN) today announced plans to release third quarter fiscal 2014 results on Monday, May 5, following the close of trading on...
-
Apr 3, 2014
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2014 earnings conference call on Thursday, May 1, 2014, at 8:00 a.m....
-
Apr 1, 2014Designed Exclusively for CareFusion by Surgical Site Solutions, Inc.
SAN DIEGO, CA, April 1, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, today announced availability of the ClipVac® hair removal system from Surgical Site Solutions,...
-
Mar 24, 2014Global Expert on Infectious Disease and Public Health
FRANKLIN LAKES, N.J., March 24, 2014 – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced the election of Dr. Claire Pomeroy to its Board of...
-
Mar 19, 2014CareFusion Places in Top 10 for Overall Software Vendor Rankings
SAN DIEGO, CA, Feb. 19, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced its MedMined® Surveillance Advisor was named the Category Leader...
-
Mar 19, 2014BD Veritor(TM) System for Rapid Detection of RSV Receives 510(k) Clearance and CLIA Waiver
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory...
-
Mar 6, 2014V. Mueller Bipolar Instruments Promote Improved Safety for Electrosurgical Procedures
SAN DIEGO,CA, March 6, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced the global launch of a new line of electrosurgical instruments...
-
Feb 25, 2014BD Veritor(TM) System for Rapid Detection of Group A Strep Receives 510(k) Clearance and CLIA Waiver
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory...
-
Feb 18, 2014Infusion pump interoperability collaboration with CareFusion and Cerner wins award for Improving the Patient Experience: Care and Safety
SAN DIEGO, CA and KANSAS CITY, MO, Feb. 18, 2014 /PRNewswire/ – The RFID in Healthcare Consortium (RHCC) and IntelligentHospital.org today announced that Children's Hospitals and Clinics of...
-
Feb 14, 2014
BALTIMORE, MD, February 14, 2014 – BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that the company has achieved...
-
Feb 11, 2014BD and USAID Collaborate to Support National TB Program Capacity Building and Development Goals
SURABAYA, February 11, 2014 – In an ongoing effort to prevent and control infectious disease outbreaks globally, the U.S. Agency for International Development (USAID) and Becton, Dickinson and...
-
Feb 7, 2014
FRANKLIN LAKES, N.J., February 7, 2014 – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global technology company, today announced the appointment of Amit Bhalla as Vice President,...
-
Feb 7, 2014
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in February 2014:...
-
Feb 4, 2014-- Raises the bottom end of full fiscal year 2014 revenue and earnings ranges for guidance.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.0 billion for the first fiscal quarter ended December 31, 2013,...
-
Feb 3, 2014Second quarter revenue increased to $922 million, driven by continued strength in the company's Procedural Solutions segment
SAN DIEGO, CA, Feb. 3, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its second quarter of fiscal 2014,...
-
Jan 29, 2014CareFusion, Terumo Sign Distribution Agreement For IV Catheters
SAN DIEGO, CA, Jan. 29, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, and Terumo Corporation, the largest medical technology company in Japan, today...
-
Jan 28, 2014
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 54.5 cents per common share payable on March 31, 2014 to holders of record on March...
-
Jan 14, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 28,...
-
Jan 13, 2014BD MAX(TM) MRSA XT Assay with eXTended Detection Technology Receives FDA Clearance
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has received FDA clearance to market the BD MAX(TM) MRSA XT
-
Jan 10, 2014
SAN DIEGO, CA, Jan. 9, 2014 /PRNewswire/ – CareFusion Corporation (NYSE: CFN) today announced plans to release second quarter fiscal 2014 results on Monday, Feb. 3, following the close of...
-
Jan 9, 2014
SAN DIEGO, CA, Jan. 9, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN) today issued the following statement regarding a previously disclosed settlement agreement: Today, the U.S. Department of...
-
Jan 7, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2014 earnings conference call on Tuesday, February 4, 2014, at 8:00...
-
Jan 7, 2014Advances BD Diagnostics' Point-of-Care Strategy
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired Alverix, Inc., a privately-held diagnostic instrument company...
-
Jan 5, 2014In response to a recent media story regarding the validity of a CareFusion-funded clinical study, CareFusion issued the following statement:
Our products are safe and effective. In particular, our skin prep product, ChloraPrep, has been proven effective when used in conjunction with best clinical practices to effectively kill...